Navigation Links
Gen-Probe to Webcast Presentation at the Canaccord Adams 29th Annual Global Growth Conference
Date:8/3/2009

SAN DIEGO, Aug. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Canaccord Adams 29th Annual Global Growth Conference on Tuesday, August 11, 2009 at 2:30 p.m. Eastern time (11:30 a.m. Pacific time). The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at www.gen-probe.com. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective NATs that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people. For more information, go to www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended March 31, 2009, and all subsequent periodic filings. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

    Contact:
    Paula Izidoro
    Investor Relations
    858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gen-Probe Reports Financial Results for Second Quarter 2009
2. Gen-Probe to Webcast Two Upcoming Investor Presentations
3. Gen-Probe Reports Financial Results for First Quarter 2009
4. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
5. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
6. Tepnel Shareholders Approve Acquisition by Gen-Probe
7. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
8. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
9. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
10. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
11. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The American ... audiologists—to remain a critical part of public access to hearing aid technology. , ... announced this week that, starting immediately, it would no longer enforce the ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... planning assistance from offices in Pasco and Richland, is initiating a charity drive ... serious injuries resulting from a recent automobile collision. , On October 29th ...
(Date:12/9/2016)... ... December 09, 2016 , ... Cellairis is a worldwide mobile device and ... iPhone , iPad and Samsung Galaxy devices with premium parts and accessories. ... to maximize convenience and accessibility for customers. While customers do their shopping, Cellairis can ...
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company is a ... As a means of expanding capabilities Flottman has added a G&K Vijuk TTM ... professional inserts (PIs) and patient package inserts (PPIs) that will marry with all ...
(Date:12/9/2016)... PITTSBURGH, PA (PRWEB) , ... December 09, 2016 , ... ... Miami, Fla. "I used this old family recipe, which is meant to relieve gout ... and it gave me a 12-hour energy boost every time. It relieved what VA ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... CITY, Calif. , Dec. 9, 2016  Nevro ... device company that is providing innovative evidence-based solutions for ... Scientific (NYSE: BSX ) has filed a ... United States District Court for the District of ... Boston Scientific,s patents covering technology related to stimulation leads, ...
(Date:12/9/2016)... -- MSD, a nationally recognized supplier of technology enabled ... health care facilities, announced today that it has completed ... a privately held national distributor of medical supplies and ... segments. We would like to welcome First Choice to ... will deliver significant and immediate value to MSD,s customers ...
(Date:12/9/2016)... LONDON , December 9, 2016 ... ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac ... External Defibrillators, Wearable Cardioverter Defibrillators The ... grow at a CAGR of 5.3% from 2016-2020 ... is expected to grow at a CAGR of ...
Breaking Medicine Technology: